{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:19:29Z","timestamp":1781806769199,"version":"3.54.5"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.autrev.2014.12.003","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T08:33:51Z","timestamp":1418373231000},"page":"332-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Why treatments do(n't) work in vitiligo: An autoinflammatory perspective"],"prefix":"10.1016","volume":"14","author":[{"given":"Reinhart","family":"Speeckaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn M.","family":"Speeckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanja","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.12.003_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.autrev.2010.02.013","article-title":"Current remedies for vitiligo","volume":"9","author":"Abu Tahir","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.12.003_bb0010","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2133.1998.02550.x","article-title":"Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules","volume":"139","author":"Hedley","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2133.2010.10039.x","article-title":"Role of apoptosis and melanocytorrhagy: a comparative study of melanocyte adhesion in stable and unstable vitiligo","volume":"164","author":"Kumar","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0025","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jdv.12013","article-title":"Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin","volume":"27","author":"Reichert-Faria","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/pcmr.12208","article-title":"Preferential secretion of inducible HPS70 by vitiligo melanocytes under stress","volume":"27","author":"Mosenson","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/exd.12183","article-title":"A central role for inducible heat-shock protein 70 in autoimmune vitiligo","volume":"22","author":"Mosenson","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0040","doi-asserted-by":"crossref","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.12.003_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","article-title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","volume":"144","author":"Jimbow","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0050","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"Van den Broon","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.anndiagpath.2014.01.002","article-title":"Immunohistochemical expression of aberrant Notch-1 signalling in vitiligo: an implication for pathogenesis","volume":"18","author":"Seleit","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5021\/ad.2012.24.2.115","article-title":"Role of keratinocytes in the development of vitiligo","volume":"24","author":"Lee","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjd.12691","article-title":"Inflammasome activation and vitiligo\/nonsegmental vitiligo progression","volume":"170","author":"Marie","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.06739.x","article-title":"FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus induces repigmentation in patient with vitiligo","volume":"153","author":"Lan","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.0906-6705.2004.00221.x","article-title":"Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes","volume":"13","author":"Wu","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jdermsci.2014.07.005","article-title":"Effects of 1,25-dihydroxyvitamin D3 on human epidermal melanocytes and melanoblasts","volume":"76","author":"Kawakami","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2014.12.003_bb0085","article-title":"Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial","author":"Lim","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2008.08923.x","article-title":"Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo","volume":"160","author":"Kapoo","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.12442","article-title":"Improvement of vitiligo in a patient with rheumatoid arthritis after hydroxychloroquine treatment","author":"Joo","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2014.12.003_bb0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/exd.12202","article-title":"Targeting iHSP70 in vitiligo: a critical step for cure?","volume":"22","author":"Ta\u00efeb","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/02656736.2013.811546","article-title":"Heat shock proteins can be targets of regulatory T cells for therapeutic intervention in rheumatoid arthritis","volume":"29","author":"Van Herwijnen","year":"2013","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.autrev.2014.12.003_bb0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","article-title":"Vitiligo puzzle: the pieces fall in place","volume":"20","author":"Westerhof","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0120","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/jid.2014.152","article-title":"Impaired activation of the Nrf2-ARE signalling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo","volume":"134","author":"Jian","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/exd.12151","article-title":"Commentary from the editorial board to vitiligo: interplay between oxidative stress and immune system (Laddha et al.)","volume":"22","author":"Colucci","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.pathol.4.110807.092239","article-title":"NOD-like receptors: role in innate immunity and inflammatory disease","volume":"4","author":"Chen","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0300060513516294","article-title":"Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy","volume":"42","author":"Karsli","year":"2014","journal-title":"J Int Med Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00403-009-0973-3","article-title":"Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus","volume":"302","author":"Lubaki","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1755-148X.2009.00615.x","article-title":"Alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes","volume":"22","author":"Song","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0155","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/1541-7786.MCR-11-0436","article-title":"Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signalling pathway in human melanocytes","volume":"10","author":"Kadkaro","year":"2012","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0160","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1210\/en.2008-1315","article-title":"Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2-dependent gene expression in human skin","volume":"150","author":"Kokot","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2014.12.003_bb0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0300060513516294","article-title":"Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy","volume":"42","author":"Karsli","year":"2014","journal-title":"J Int Med Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/0091270009335769","article-title":"Response of vitiligo to narrowband ultraviolet B and oral antioxidants","volume":"49","author":"Elgoweini","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0185","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1073\/pnas.1222808110","article-title":"NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1\u03b2 processing via the NLRP1 inflammasome","volume":"110","author":"Levandowski","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2014.12.003_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0195","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0200","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"15","author":"Laddha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.12.003_bb0205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1755-148X.2010.00703.x","article-title":"First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi","volume":"23","author":"van Geel","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0210","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","article-title":"Therapeutic implications of autoimmune vitiligo T cells","volume":"5","author":"Oyarbide-Valencia","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.12.003_bb0220","doi-asserted-by":"crossref","first-page":"684","DOI":"10.18632\/oncotarget.323","article-title":"New perspectives on the role of vitiligo in immune responses to melanoma","volume":"2","author":"Byrne","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2014.12.003_bb0225","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1346-8138.1998.tb02472.x","article-title":"Peripheral T-cell activation in non-segmental vitiligo","volume":"25","author":"Mahmoud","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0230","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.autrev.2013.01.004","article-title":"Vogt\u2013Koyanagi\u2013Harada syndrome","volume":"12","author":"Greco","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.12.003_bb0235","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3892\/etm.2014.1975","article-title":"Protein tyrosinase phosphatase PTPN22+ 1858C\/T polymorphism is associated with active vitiligo","volume":"8","author":"Garcia-Melendez","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.autrev.2014.12.003_bb0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0245","doi-asserted-by":"crossref","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.12.003_bb0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1755-148X.2011.00892.x","article-title":"Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype\u2013phenotype correlation","volume":"24","author":"Dwivedi","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0255","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1684\/ejd.2013.2023","article-title":"Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case-controlled study on eighty-four patients","volume":"23","author":"Elela","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","article-title":"Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris","volume":"25","author":"Kotobuki","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0265","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1\u03b2 and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/exd.12369","article-title":"T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo","volume":"23","author":"Hegazy","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1755-148X.2011.00922.x","article-title":"In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial","volume":"25","author":"van Geel","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0280","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaci.2004.05.066","article-title":"Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment","volume":"114","author":"Simon","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0285","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jaci.2005.02.011","article-title":"Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis","volume":"115","author":"Hoetzenecker","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0290","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.ajpath.2011.02.016","article-title":"Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanisms","volume":"178","author":"Rana","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0295","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/phpp.12104","article-title":"Effect of narrow band-ultraviolet B on CD4(+) CD25(high) FoxP3(+) T-lymphocytes in the peripheral blood of vitiligo patients","volume":"30","author":"Moftah","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.autrev.2014.12.003_bb0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporin in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jsps.2012.12.003","article-title":"Methotrexate for the treatment of generalized vitiligo","volume":"21","author":"Alghamdi","year":"2013","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.autrev.2014.12.003_bb0310","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","article-title":"The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.autrev.2014.12.003_bb0315","article-title":"The combination of tumour necrosis factor-alpha-308A and interleukin-10-1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo","author":"Ayding\u00f5z","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxal immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-alpha agents","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.12.003_bb0325","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0330","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0335","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.12.003_bb0340","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jid.2009.207","article-title":"Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library","volume":"130","author":"Waterman","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0345","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.12.003_bb0350","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cei.12168","article-title":"Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study","volume":"174","author":"Ruiz-Arg\u00fcelles","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0355","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1468-3083.2012.04501.x","article-title":"Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo","volume":"27","author":"Kroon","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0360","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/pcmr.12294","article-title":"The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo","volume":"27","author":"Teulings","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0365","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/bjd.13286","article-title":"High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients","volume":"171","author":"Colucci","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0370","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cei.12096","article-title":"Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo","volume":"173","author":"Sanchez-Sosa","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.12.003_bb0375","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.autrev.2014.12.003_bb0380","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1365-2133.2011.10430.x","article-title":"Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin","volume":"165","author":"Heier","year":"2011","journal-title":"Br J Dermatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214003000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214003000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T20:53:30Z","timestamp":1717620810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214003000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1568997214003000"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.12.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why treatments do(n't) work in vitiligo: An autoinflammatory perspective","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}